diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: voluntary participation; At least 1 year and a maximum of 10 years diabetes history and observing at least 6 months diabetic diet; taking oral drugs lowering blood glucose to control diabetes; 18 to 65 years old; Lack of pregnancy and lactation; Not having certain diseases (liver, kidney, heart, thyroid, rheumatoid, respiratory, metabolic, gastrointestinal, malignancy, allergic diseases); no need for insulin; not using dietary, vitamin and mineral supplements, at least three months before the study; not hormone therapy; no smoking; no using other medicinal plants routinely, at least 3 months prior to the study exclusion criteria: unwillingness to continue; developing specific diseases (liver, kidney, heart, thyroid, rheumatoid, respiratory, metabolic, gastrointestinal, malignancy, allergic diseases) during the study; starting pregnancy and lactation; starting insulin therapy; starting using dietary, vitamin and mineral supplements; change in the dose of oral blood glucose lowering drugs; Change in the physical activity during the study; start taking other medicinal plants routinely
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor necrosis factor-a. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Total antioxidant capacity. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Interleukin-6. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Glutathione peroxidase. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Superoxide dismutase. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;High-sensitivity C-reactive protein. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level by ELISA kit.;Fasting blood glucose. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;2-hour post prandial glucose. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of serum level.;Hemoglobin A1C. Timepoint: before intervention and 2 months after starting the intervention. Method of measurement: Measurement of blood level. | — |
Countries
Iran (Islamic Republic of)
Contacts
School of Nutrition and Food Sciences, Isfahan University of Medical Sciences